Abstract 2: Financial Toxicity From Out-of-pocket Annual Health Expenditures in Low-income Adults With Atherosclerotic Cardiovascular Disease in the United States [Session Title: QCOR 2018 Young Investigator Award Finalists]
Conclusion: 1 in 4 low-income families with a member with ASCVD experience a high financial burden, and 1 in 10 experience a catastrophic healthcare expense, even with insurance coverage. Underinsurance of low-income families has improved minimally. To alleviate economic disparities, policy interventions must extend focus to improving the quality of coverage for low-income families. (Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - April 5, 2018 Category: Cardiology Authors: Khera, R., Valero-Elizondo, J., Okunrintemi, V., Saxena, A., de Lemos, J. A., Krumholz, H. M., Nasir, K. Tags: Session Title: QCOR 2018 Young Investigator Award Finalists Source Type: research

Abstract 1: The Impact of State Medicaid Expansions on Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure [Session Title: QCOR 2018 Young Investigator Award Finalists]
Conclusion: The ACA Medicaid state expansions were not associated with improvements in quality of care or in-hospital mortality in expansion states among sites participating in a national quality improvement initiative. Future investigation should evaluate the long-term impact of expansion on HF care during the post-discharge period. (Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - April 5, 2018 Category: Cardiology Authors: Wadhera, R. K., Joynt Maddox, K. E., Fonarow, G. C., Zhao, X., Heidenreich, P. A., DeVore, A. D., Matsouaka, R., Hernandez, A. F., Yancy, C. W., Bhatt, D. L. Tags: Session Title: QCOR 2018 Young Investigator Award Finalists Source Type: research

Does a Target Dose or a Target Heart Rate Matter to Outcomes When Prescribing {beta}-Blockers to Patients With Chronic Heart Failure? [Cardiovascular Perspective]
(Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - April 5, 2018 Category: Cardiology Authors: Packer, M. Tags: Heart Failure Cardiovascular Perspective Source Type: research

The Ultimate Goal Post [Editor's Note]
(Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - April 2, 2018 Category: Cardiology Authors: Nallamothu, B. K., Editor, Circulation: Cardiovascular Quality & Outcomes Tags: Quality and Outcomes Editor ' s Note Source Type: research

Correction to: Moving the Goalposts Into Unblinded Territory: The Larger Lessons of DEFER and FAME 2 and Their Implications for Shifting End Points in ISCHEMIA ['Faith Healing and 'Subtraction Anxiety in Unblinded Trials of Procedures: Lessons from DEFER and FAME-2 for End Points in the ISCHEMIA Trial] [Correction]
(Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - April 2, 2018 Category: Cardiology Tags: Correction Source Type: research

2018 ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures [Performance Measures]
(Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - March 29, 2018 Category: Cardiology Authors: Thomas, R. J., Balady, G., Banka, G., Beckie, T. M., Chiu, J., Gokak, S., Ho, P. M., Keteyian, S. J., King, M., Lui, K., Pack, Q., Sanderson, B. K., Wang, T. Y. Tags: Statements and Guidelines Performance Measures Source Type: research

Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China [Original Articles]
Conclusions: Early intravenous TCM use for AMI in China is increasing despite the lack of evidence of their benefit or harm. There is an urgent need to define the effects of these medications because they have become a staple of treatment in the world’s most populous country. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01624883 (Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - March 16, 2018 Category: Cardiology Authors: Spatz, E. S., Wang, Y., Beckman, A. L., Wu, X., Lu, Y., Du, X., Li, J., Xu, X., Davidson, P. M., Masoudi, F. A., Spertus, J. A., Krumholz, H. M., Jiang, L. Tags: Myocardial Infarction, Quality and Outcomes Original Articles Source Type: research

Understanding How Patients Fare: Insights Into the Health Status Patterns of Patients With Coronary Disease and the Future of Evidence-Based Shared Medical Decision-Making [Editorial]
(Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - March 15, 2018 Category: Cardiology Authors: Spertus, J. A. Tags: Mortality/Survival, Quality and Outcomes Editorial Source Type: research

Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry [Data Report]
(Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - March 15, 2018 Category: Cardiology Authors: Navar, A. M., Peterson, E. D., Li, S., Robinson, J. G., Roger, V. L., Goldberg, A. C., Virani, S., Wilson, P. W. F., Nanna, M. G., Lee, L. V., Elassal, J., Wang, T. Y. Tags: Quality and Outcomes Data Report Source Type: research

Trajectories of Health-Related Quality of Life in Coronary Artery Disease [Original Articles]
Conclusions: This study highlights variations in longitudinal trajectories of HRQOL in patients with CAD. Despite overall improvements in HRQOL, about a quarter of our cohort experienced a significant decline in their HRQOL over the 5-year period. Understanding these HRQOL trajectories may help personalize prognostic information, identify patients and HRQOL domains on which clinical interventions are most beneficial, and support treatment decisions for patients with CAD. (Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - March 15, 2018 Category: Cardiology Authors: Sajobi, T. T., Wang, M., Awosoga, O., Santana, M., Southern, D., Liang, Z., Galbraith, D., Wilton, S. B., Quan, H., Graham, M. M., James, M. T., Ghali, W. A., Knudtson, M. L., Norris, C., for the APPROACH Investigators Tags: Cardiovascular Disease, Epidemiology, Percutaneous Coronary Intervention, Revascularization, Quality and Outcomes Original Articles Source Type: research

Clinical Outcomes of Plavix and Generic Clopidogrel for Patients Hospitalized With an Acute Coronary Syndrome [Original Articles]
Conclusions: Generic clopidogrel was noninferior to Plavix with respect to the composite end point of death and recurrent hospitalization for ACS at 1 year among adults >65 years after an ACS hospitalization. Our findings support generic clopidogrel in ACS, which could lead to substantial healthcare cost savings. (Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - March 13, 2018 Category: Cardiology Authors: Ko, D. T., Krumholz, H. M., Tu, J. V., Austin, P. C., Stukel, T. A., Koh, M., Chong, A., de Melo, J. F., Jackevicius, C. A. Tags: Health Services, Mortality/Survival Original Articles Source Type: research

'Faith Healing and 'Subtraction Anxiety in Unblinded Trials of Procedures: Lessons from DEFER and FAME-2 for End Points in the ISCHEMIA Trial [Cardiovascular Perspective]
(Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - March 12, 2018 Category: Cardiology Authors: Rajkumar, C. A., Nijjer, S. S., Cole, G. D., Al-Lamee, R., Francis, D. P. Tags: Chronic Ischemic Heart Disease, Percutaneous Coronary Intervention, Quality and Outcomes Cardiovascular Perspective Source Type: research

Moving the Goalposts Into Unblinded Territory: The Larger Lessons of DEFER and FAME 2 and Their Implications for Shifting End Points in ISCHEMIA [Cardiovascular Perspective]
(Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - March 12, 2018 Category: Cardiology Authors: Rajkumar, C. A., Nijjer, S. S., Cole, G. D., Al-Lamee, R., Francis, D. P. Tags: Chronic Ischemic Heart Disease, Percutaneous Coronary Intervention, Quality and Outcomes Cardiovascular Perspective Source Type: research

Association Between 30-Day Episode Payments and Acute Myocardial Infarction Outcomes Among Medicare Beneficiaries [Original Articles]
Conclusions: Higher hospital-level 30-day payments—both inpatient and in multiple settings after discharge—for AMI care were associated with lower 30-day mortality among beneficiaries. This may have implications for payment programs that incent reduction in payments without considering value. (Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - March 12, 2018 Category: Cardiology Authors: Wadhera, R. K., Joynt Maddox, K. E., Wang, Y., Shen, C., Bhatt, D. L., Yeh, R. W. Tags: Health Services, Quality and Outcomes Original Articles Source Type: research

A Novel Tool for Visualizing Composite Endpoint Associations [Data Visualizations]
(Source: Circulation: Cardiovascular Quality and Outcomes)
Source: Circulation: Cardiovascular Quality and Outcomes - February 26, 2018 Category: Cardiology Authors: Breitling, L. P. Tags: Epidemiology, Risk Factors Data Visualizations Source Type: research